The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor

Background and Purpose: Immunotherapy has shown great efficacy in many cancers, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unclear. The objective of this study was to investigate the impact of immunotherapy on the overall survival of PDAC patients who did not receive definitive...

Full description

Bibliographic Details
Main Authors: Saber Amin, Michael Baine, Jane Meza, Morshed Alam, Chi Lin
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630820300513